The median serum level of Ang-2 at baseline was 3493 pg/mL for lung cancer patients and was significantly higher than that of controls (median concentration; 3493 pg/mL vs. 2148 pg/mL, p < 0.0001, Table 1, Figure 1). Here, ANGPT2 is linked to lung cancer.